Skip to main content
Log in

Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative Chemoradiotherapy

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

Purpose

The aim of this study was to evaluate downstaging as primary end point, and progression-free survival and overall survival as secondary end points, in rectal adenocarcinoma patients treated with preoperative chemoradiation.

Methods

One hundred and thirty-six extraperitoneal adenocarcinoma patients (33 low rectum T2, 74 T3, 29 T4 [without sacral invasion], 25 with mucinous subtype) were treated with posterior pelvis preoperative radiotherapy (5040 cGy total dose, 180 cGy/fr, 5 fr/w, 10–15 MV linac X-rays) and concomitant 5-fluorouracil-based chemotherapy. After 6 to 8 weeks patients underwent surgery and prechemoradiation clinical stage was compared with pathologic stage to evaluate downstaging in each patient. Seventy-four patients received adjuvant chemotherapy. Median follow-up was 39 months (4–84).

Results

Forty-four patients had macroscopic complete response, 52 patients had partial response, 37 patients showed no change and 3 patients had progression. At multivariate analysis only histotype showed correlation with downstaging (hazard ratio = 0.350 and 0.138 – 0.885 95 percent confidence interval) because of the evidence for poor downstaging in mucinous subtype. There were no significant differences in overall survival and progression-free survival between adenocarcinoma and mucinous subtype.

Conclusions

The main finding is that mucinous histology is associated with poor downstaging after preoperative chemoradiation but this poor response was not associated with worse outcome in this small study. The good outcome for mucinous histology is at odds with other reports in the literature and requires further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553–9.

    Article  PubMed  CAS  Google Scholar 

  2. Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883–8.

    Article  PubMed  CAS  Google Scholar 

  3. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987–95.

    Article  PubMed  CAS  Google Scholar 

  4. Valentini V, Coco C, Cellini N, et al. Ten years of preoperative chemoradiation for extra peritoneal T3 rectal cancer: acute toxicity, tumour response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001;51:371–83.

    Article  PubMed  CAS  Google Scholar 

  5. Crane CH, Skibber JM, Birnbaum EH, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84–9.

    Article  PubMed  CAS  Google Scholar 

  6. Withers HR, Haustermans K. Where next with preoperative radiation therapy for rectal cancer? Int J Radiat Oncol Biol Phys 2004;58:597–602.

    Article  PubMed  Google Scholar 

  7. Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer 1989;63:1421–9.

    Article  PubMed  CAS  Google Scholar 

  8. Williamson PR, Hellinger MD, Larach SW, Ferrara A. Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis Colon Rectum 1996;39:45–9.

    Article  PubMed  CAS  Google Scholar 

  9. Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218–24.

    PubMed  CAS  Google Scholar 

  10. Minsky BD. Adjuvant therapy of rectal cancer. Semin Oncol 1999;26:540–4.

    PubMed  CAS  Google Scholar 

  11. Capirci C, Polico C, Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields using new “up down table” device. Int J Radiat Oncol Biol Phys 2001;51:465–73

    Article  PubMed  CAS  Google Scholar 

  12. International Commission on Radiation Units and Measurements. ICRU report 50: prescribing, recording and reporting photon beam therapy. Bethesda, MD: Oxford University Press, 1993

    Google Scholar 

  13. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott, 1992:1–62

  14. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumour regression after preoperative chemo-radiotherapy of oesophageal carcinoma. Clinic-pathologic correlations. Cancer 1994;73:2680–6.

    Article  PubMed  CAS  Google Scholar 

  15. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457–81.

    Article  Google Scholar 

  16. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187–220.

    Google Scholar 

  17. Sobin LH, Wittekind Ch, eds. UICC International Union Against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002

  18. Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy for rectal cancer. Predictive factors of tumor downstaging and residual tumor cell density. Prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619–27.

    Article  PubMed  CAS  Google Scholar 

  19. Kaminsky-Forret MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935–41.

    Article  Google Scholar 

  20. Janjan NA, Abbruzzese J, Pazdur R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 1999;51:153–60.

    Article  PubMed  CAS  Google Scholar 

  21. Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of post-chemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075–80.

    Article  PubMed  CAS  Google Scholar 

  22. Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002;53:664–74.

    Article  PubMed  Google Scholar 

  23. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94:1121–30.

    Article  PubMed  Google Scholar 

  24. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891–900.

    Article  PubMed  CAS  Google Scholar 

  25. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000;75:103–7.

    Article  PubMed  CAS  Google Scholar 

  26. Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994;51:30–4

    Article  PubMed  CAS  Google Scholar 

  27. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 2000;73:70–4

    Article  PubMed  CAS  Google Scholar 

  28. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Pathology Review Committee. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002;197:20–7

    Article  PubMed  Google Scholar 

  29. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB, Ray JE. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum 1993;36:49–54

    Article  PubMed  CAS  Google Scholar 

  30. Jessup JM, Loda M, Bleday R. Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer. Semin Radiat Oncol 1998;8:54–69.

    Article  PubMed  CAS  Google Scholar 

  31. Hussain SM, Outwater EK, Siegelman ES. MR imaging features of pelvic mucinous carcinomas. Eur Radiol 2000;10:885–91.

    Article  PubMed  CAS  Google Scholar 

  32. Hussain SM, Outwater EK, Siegelman ES. Mucinous vs. non mucinous rectal carcinomas: differentiation with MR imaging. Radiology 1999;213:79–85.

    PubMed  CAS  Google Scholar 

  33. Kim MJ, Park JS, Park SI, et al. Accuracy in differentiation of mucinous and non mucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr 2003;27:48–55.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Filippo Grillo-Ruggieri M.D..

About this article

Cite this article

Grillo-Ruggieri, F., Mantello, G., Berardi, R. et al. Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative Chemoradiotherapy. Dis Colon Rectum 50, 1594–1603 (2007). https://doi.org/10.1007/s10350-007-9026-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-007-9026-1

Key words

Navigation